|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/14/24 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 23/14/23 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 01/10/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 01/04/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/01/2015 | |
Haruhisa Inada
BRD | Director/Board Member | - | 30/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 01/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.98% | +2.50% | -5.63% | -25.98% | 25TCr | ||
| -1.82% | -1.81% | -40.09% | -55.71% | 4.24TCr | ||
| -2.39% | +2.74% | -34.50% | -44.86% | 2.23TCr | ||
| -2.57% | +0.88% | -28.29% | -61.01% | 1.95TCr | ||
| +1.39% | +1.56% | +16.43% | +55.66% | 1.14TCr | ||
| -2.38% | -0.64% | -41.94% | -70.35% | 906.38Cr | ||
| +1.17% | +1.38% | -7.31% | -50.19% | 837.9Cr | ||
| -1.06% | +8.37% | -32.52% | -62.29% | 695.59Cr | ||
| -0.93% | +9.17% | -25.28% | -48.08% | 550.14Cr | ||
| Average | -1.06% | +0.10% | -22.13% | -40.31% | 4.16TCr | |
| Weighted average by Cap. | -1.16% | -0.69% | -13.48% | -32.43% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















